If approved, TLX250-CDx will become the first commercially available imaging agent to accurately and non-invasively diagnose and characterize clear cell renal cell carcinoma (ccRCC), the most common ...
7h
Investing News Network on MSNStem Cell Stocks: 10 Biggest NASDAQ Companies in 2025Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...
The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.
There is a dose-response relationship between physical activity and rapid kidney function decline in older adults, according ...
Three months after her breakthrough surgery at NYU Langone Health, Towana Looney, the longest-living recipient of a genetically engineered pig kidney, is headed back home to Alabama.
There is a donated kidney shortage in the U.S. Its leaving more than 100,000 people on a years-long waitlist. And despite ...
Peer-reviewed articles on MediBeacon technology published Transdermal GFR System (TGFR) is a first-in-kind product for point ...
LAS VEGAS, NV / ACCESS Newswire / February 25, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology ...
15h
The Healthy on MSNOTC Medication Mistakes: Doctors Advise You To Avoid Doing TheseEvery medication, whether OTC or by prescription, needs to be taken seriously,” says Stacy Jean Willner, DO, a cardiologist ...
Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results